PLAYSTUDIOS, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated May 13, 2022 and signed May 17, 2022, reports an amendment to the company’s credit agreement and the results of an offer and consent solicitation for its public and private placement warrants.
Key Financial and Capital Structure Matters
- Amendment No. 1 to the June 24, 2021 Credit Agreement excludes up to $15 million of expenditures related to the company’s warrant purchase offer from the Fixed Charge Coverage Ratio calculation.
- The Borrower remains subject to quarterly financial covenants requiring a Total Net Leverage Ratio of no more than 3.50:1.00, subject to an increase to 4.00:1.00 following certain material acquisitions, and a Fixed Charge Coverage Ratio of at least 1.25:1.00.
- The filing does not provide revenue, profit, cash flow, margin, debt-balance, liquidity, or covenant-compliance amounts.
Material Changes Versus the Prior Comparable Period
- The credit agreement was amended to provide the specified covenant treatment for warrant-purchase expenditures.
- The warrant offer expired at midnight Eastern Time on May 13, 2022. Approximately 1.79 million public warrants, or about 25% of outstanding public warrants, were validly tendered and not withdrawn.
- No private placement warrants were validly tendered.
- Because approval from holders of approximately 25% of public warrants was below the required 65% threshold, the proposed Warrant Amendment was not approved for either the public warrants or the private placement warrants.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- The company offered to purchase warrants and sought consent to permit redemption of each outstanding public and private placement warrant for $0.90 in cash, without interest.
- The $0.90 redemption price was 10% below the purchase price offered in the warrant tender offer.
- The unsuccessful consent solicitation means the proposed warrant redemption amendment was not adopted.
- The filing does not provide management guidance or a broader business outlook. The company remains subject to the stated leverage and fixed-charge coverage covenants.
Investor Verification Items
- Verify the complete terms of Amendment No. 1, including the precise definition and treatment of excluded warrant-related expenditures.
- Confirm the company’s outstanding debt, liquidity, and compliance with the 3.50:1.00 Total Net Leverage Ratio and 1.25:1.00 Fixed Charge Coverage Ratio.
- Assess the consequences of the Warrant Amendment not receiving the required 65% approval threshold.
- Review the final tendered-warrant totals and any subsequent actions involving the public and private placement warrants.